Many clinically at-risk patients mounted low or no immune response to Covid vaccines
OCTAVE study reveals real-world vaccine response in patients with impaired immune systems
Published 6 July 2023
Leukaemia trial testing vaccine strategies to combat immune suppression
The IMPROVE clinical trial is testing whether vaccine timing can help clinically vulnerable people build antibodies
Published 8 February 2023
Immunocompromised patients remain at higher risk of COVID-19 death in hospital
Patients had 44% higher risk of death in hospital compared to those with healthy immune system function
Published 3 February 2023
Immune T cell defence is coping with COVID-19 variants of concern – for now
Broad T-cell response is currently protective but recognition of seven out of ten T-cell targets mutated in SARS-CoV-2 variants is impaired
Published 1 December 2022
University of Birmingham and European partners share Covid-19 expertise at summer school
University of Birmingham experts joined partners across Europe to explore the impact of Covid-19 on European health and well-being.
Published 8 November 2022
Antibody therapies against Covid-19 for most vulnerable patients work, new analysis finds
The largest analysis of data on antibody therapies for protecting clinically extremely vulnerable people from Covid-19 shows that they are effective.
Published 8 November 2022
Monkeypox research to benefit from genetic coding lessons taken from Covid-19
Lessons from the genetic mutations which led to Covid-19 variants such as Alpha and Omicron could help scientists tackle similar changes in Monkeypox.
Published 20 October 2022
AI takes guesswork out of lateral flow testing
A new trial found that an AI app-based reader for lateral flow devices reduced false Covid negatives in assisted test sites.
Published 18 October 2022
Spotlight on Research
Pioneering breakthroughs, multidisciplinary collaborations and significant global impact.